| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 195 | 124 | +57.6% |
| EBITDA | 30.5 | 9.0 | +239.5% |
| EBITDA margin | 15.7% | 7.3% | +8.4 pts |
| Profit before tax | 17.5 | 2.5 | +601.3% |
| Net profit | 13.3 | 4.0 | +235.0% |
| EPS | ₹1.03 | ₹0.31 | +232.3% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 2,588 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 16.4 | 16.4 | 28.8 | 48.4 | 2.9 | ||
| 231 | 231 | 84.4 | 61.4 | 50.0 | ||
| 2,803 | — | — | — | — | ||
| 607 | 536 | 440 | 408 | 502 | ||
| — | +21.7% | +8.1% | −18.8% | — | ||
| 78.7 | 57.1 | 36.9 | 42.9 | 77.3 | ||
| 13.0% | 10.7% | 8.4% | 10.5% | 15.4% | ||
| 53.3 | 36.2 | 23.1 | 31.9 | 67.5 | ||
| 27.5 | 18.2 | 13.9 | 18.2 | 45.2 | ||
| 4.5% | 3.4% | 3.2% | 4.5% | 9.0% | ||
| ₹2.12 | ₹1.40 | ₹1.07 | ₹1.41 | ₹3.48 | ||
| — | +31.1% | −24.0% | −59.6% | — | ||
| — | 12.0 | −52.8 | 34.3 | 13.9 | ||
| — | −160 | −252 | −79.1 | −59.8 | ||
| −148 | −148 | −305 | −44.8 | −45.9 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 2,588.1 | |
| - Cash, Equiv & ST Investments | 2.9 | 48.4 | 28.8 | 16.4 | 16.4 | |
| + Total Debt | 50.0 | 61.4 | 84.4 | 231.1 | 231.1 | |
| Enterprise Value | — | — | — | — | 2,802.8 | |
| Revenue | 502.1 | 407.6 | 440.5 | 535.9 | 607.2 | |
| Growth %, YoY | — | -18.8 | +8.1 | +21.7 | — | |
| EBITDA | 77.3 | 42.9 | 36.9 | 57.1 | 78.7 | |
| Margin % | 15.40 | 10.53 | 8.39 | 10.66 | 12.96 | |
| EBIT | 67.5 | 31.9 | 23.1 | 36.2 | 53.3 | |
| Net Income | 45.2 | 18.2 | 13.9 | 18.2 | 27.5 | |
| Margin % | 8.99 | 4.47 | 3.15 | 3.39 | 4.53 | |
| EPS, Adj (current shares) | 3.48 | 1.41 | 1.07 | 1.40 | 2.12 | |
| Growth %, YoY | — | -59.6 | -24.0 | +31.1 | — | |
| Cash from Operations | 13.9 | 34.3 | -52.8 | 12.0 | — | |
| Capital Expenditures | -59.8 | -79.1 | -252.3 | -160.1 | — | |
| Free Cash Flow | -45.9 | -44.8 | -305.1 | -148.1 | -148.1 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Bhagiradha Chemicals & Industries (NSE: BHAGCHEM) had a market capitalisation of ₹2,533 crore at the 30 October 2026 close (₹195.32 a share), a PE ratio of 92.0 on the last four quarters' profit and a price-to-book ratio of 3.63. In FY26 its consolidated net profit was ₹18.2 crore on revenue of ₹536 crore; in Q1 FY27 (April–June 2026) it was ₹13.3 crore, up 235.0% year on year. Its debt-to-equity ratio was 0.33 on 31 March 2026. Promoters held 19.60% of the shares on 30 September 2026.
Bhagiradha Chemicals & Industries' PE ratio is 92.0 at the 30 October 2026 close (₹195.32 a share): a market capitalisation of ₹2,533 crore divided by consolidated net profit of ₹27.5 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹18.2 crore) it is 139.4.
Bhagiradha Chemicals & Industries' price-to-book (PB) ratio is 3.63 at the 30 October 2026 close: a market capitalisation of ₹2,533 crore divided by shareholders' equity (book value) of ₹698 crore on 31 March 2026. That is a book value of ₹53.85 per share against a share price of ₹195.32.
Bhagiradha Chemicals & Industries' net worth — shareholders' equity in its consolidated balance sheet — was ₹698 crore on 31 March 2026, up 2.4% from ₹682 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹2,533 crore at the 30 October 2026 close.
Bhagiradha Chemicals & Industries' market capitalisation was ₹2,533 crore at the 30 October 2026 close: 12.97 crore shares at ₹195.32 each.
Bhagiradha Chemicals & Industries' debt-to-equity ratio was 0.33 on 31 March 2026: borrowings of ₹231 crore against total equity of ₹698 crore. A year earlier, on 31 March 2025, it was 0.12.
Bhagiradha Chemicals & Industries' basic earnings per share (EPS) were ₹1.40 in FY26, against ₹1.14 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹2.12.
No. Bhagiradha Chemicals & Industries had borrowings of ₹231 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.33. Its cash and current investments were ₹18.9 crore, so its net debt was ₹212 crore.
Bhagiradha Chemicals & Industries' book value per share was ₹53.85 on 31 March 2026: shareholders' equity of ₹698 crore divided by the 12.97 crore shares in issue, up 2.4% from ₹52.61 a year earlier. The share price at the 30 October 2026 close was ₹195.32.
Bhagiradha Chemicals & Industries' dividend yield is 0.08% at the 30 October 2026 close: dividends of ₹0.15 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹195.32. They were ₹0.15 on 23 July 2026.
In FY26, Bhagiradha Chemicals & Industries' return on equity (ROE) was 2.6% and its return on capital employed (ROCE) was 4.5%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 2.5% and ROCE 3.9%.
On 30 September 2026, Bhagiradha Chemicals & Industries' shares were held by promoters 19.60%, foreign portfolio investors (FII/FPI) 0.08%, domestic institutions (DII) 3.01% and retail and other non-institutional investors 77.31%. Over the year, FII holding was up 0.03 percentage points from 0.05% and DII holding was up 0.12 percentage points from 2.89%.
On FY26 consolidated figures, against NACL Industries and GSP Crop Science: Bhagiradha Chemicals & Industries' operating margin of 6.8% is the second highest of the three (NACL Industries 4.5%, GSP Crop Science 10.2%; peer average 7.3%); its return on equity of 2.6% is the highest of the three (NACL Industries 0.8%, GSP Crop Science −0.4%; peer average 0.2%).
In 2026, Bhagiradha Chemicals & Industries has declared one dividend: ₹0.15 with record date 23 July 2026.
Promoters held 19.60% of Bhagiradha Chemicals & Industries on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
Bhagiradha Chemicals & Industries will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
In FY26, Bhagiradha Chemicals & Industries generated ₹12 crore of cash from operations and spent ₹160 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹148 crore. In FY25 it was −₹305 crore.
Bhagiradha Chemicals & Industries' latest results are for Q1 FY27 (April–June 2026), filed on 3 August 2026: consolidated net profit ₹13.3 crore, up 235.0% from ₹4 crore in Q1 FY26; revenue from operations ₹195 crore, up 57.6% year on year.
In FY26 (April 2025–March 2026), Bhagiradha Chemicals & Industries' consolidated net profit was ₹18.2 crore, up 31.1% from ₹13.9 crore in FY25, on revenue from operations of ₹536 crore (up 21.7%). Over three years, from FY23, net profit was down 59.8%.
In FY26, Bhagiradha Chemicals & Industries earned net profit of ₹18.2 crore on revenue of ₹536 crore, against ₹4.6 crore on ₹1,584 crore for NACL Industries. Bhagiradha Chemicals & Industries' operating margin was 6.8% (NACL Industries 4.5%) and its return on equity 2.6% (NACL Industries 0.8%). At the 30 October 2026 close, Bhagiradha Chemicals & Industries' market capitalisation was ₹2,533 crore against ₹2,590 crore for NACL Industries, and its PE ratio on FY26 profit 139.4 against 566.7.
From Bhagiradha Chemicals & Industries' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.